Yatharth Hospitals: A Growth Analysis
Yatharth Hospitals, a growing healthcare company in North India, is planning a big expansion. Experts predict strong growth for the company over the next few years. They believe Yatharth will grow its bed capacity significantly, reaching almost 5,000 beds by 2030.
Key Points
- Strong growth predicted: 30% revenue, 31% EBITDA CAGR.
- Bed capacity will increase to nearly 5,000 by 2030.
- Stock valuation: currently trades at 17x FY27E EV/Ebitda.
- Revenue grew 30% from FY22 to FY25, doubling bed base.
- Focus on premium areas & new specialties for higher profits.
- Strong financial position with significant cash reserves.
The analysts at Nuvama Securities are optimistic. They forecast a substantial increase in revenue and profits – around 30% annual growth in revenue and 31% annual growth in earnings before interest, taxes, depreciation, and amortization (EBITDA) between 2025 and 2028.
This growth is driven by Yatharth’s plan to build many more hospital beds. Currently, they have about 2,500 beds, and they intend to have nearly 5,000 beds by 2030. They’re doing this by opening new hospitals in key areas like Delhi, Faridabad, and Agra.
Currently, Yatharth’s stock is valued at 17 times its expected earnings for 2027. The analysts suggest a target price of ₹920. This is based on a valuation of 20 times its expected earnings for the first half of 2028.
Yatharth has already shown impressive growth – its revenue increased by 30% from 2022 to 2025, and the number of beds has almost doubled from 864 in 2021 to 1,605 in 2025.
To achieve further growth, Yatharth plans to improve its hospitals in Noida, which are already doing well. They expect these hospitals to grow by about 14% each year as more patients use them, and as they focus on providing specialized care and different types of payment options.
The company also expects to attract more international patients – currently, less than 5% of their patients come from overseas, but they aim for nearly 10% by utilizing the upcoming Jewar airport for better connections.
Another factor will be changes in government healthcare payments, which will decrease to 30% and increased prices from the CGHS. These changes should help Yatharth make more money.
While expanding, Yatharth might see its profit margins decrease by about 100 basis points (bps) in 2026. However, they expect these margins to recover to around 25% by 2028 as the new hospitals become more established.
Yatharth has a solid financial position, with a lot of cash (₹370 crore) and a steady flow of money from its operations (₹200 crore). They plan to invest ₹1,500 crore over the next four years to build these new hospitals.
To build trust, Yatharth is taking steps to improve its operations. They’ve hired an independent auditor (BDO), added more experienced board members, and resolved issues with the Income Tax department.
However, there are some risks to watch out for, such as government healthcare payments affecting cash flow, a bad ruling in a legal dispute, increased competition in Noida, and slower-than-expected progress in building the new hospitals.
Takeaway: Yatharth’s ambitious expansion plan, combined with strategic investments, presents a promising growth trajectory for the healthcare company.
